Acrivon Therapeutics, Vincerx Pharma, MyMD Pharmaceuticals, Vivos Therapeutics, are some of the biotech stocks which are making significant moves in Tuesday's pre-market (as of 8.30 A.M. ET).
In the Green
Acrivon Therapeutics, Inc. (ACRV) is up over 65% at $9.78.MyMD Pharmaceuticals, Inc. (MYMD) is up over 30% at $3.40.Vivos Therapeutics, Inc. (VVOS) is up over 20% at $3.65.Addex Therapeutics Ltd (ADXN) is up over 19% at $26.15.Aldeyra Therapeutics, Inc. (ALDX) is up over 7% at $4.71.Syros Pharmaceuticals, Inc. (SYRS) is up over 7% at $4.82.Alkermes plc (ALKS) is up over 6% at $27.72.Taysha Gene Therapies, Inc. (TSHA) is up over 5% at $2.83.NLS Pharmaceutics Ltd. (NLSP) is up over 5% at $0.15.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.